Commentary: Not a "checkmate," but great progress

J Thorac Cardiovasc Surg. 2022 Aug;164(2):438-439. doi: 10.1016/j.jtcvs.2021.08.076. Epub 2021 Sep 8.

Authors

Brendon M Stiles¹, Marc Vimolratana²

Affiliations

¹ Department of Cardiothoracic and Vascular Surgery, Montefiore Health System, Albert Einstein College of Medicine, Bronx, NY. Electronic address: brstiles@montefiore.org.
² Department of Cardiothoracic and Vascular Surgery, Montefiore Health System, Albert Einstein College of Medicine, Bronx, NY.

PMID: 34654561
DOI: 10.1016/j.jtcvs.2021.08.076

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antineoplastic Agents, Immunological*
Humans
Nivolumab*

Substances

Antineoplastic Agents, Immunological
Nivolumab